Top Ten Trends in Biomedicine in 2015
March 03, 2015 Source: Health
Window._bd_share_config={ "common":{ "bdSnsKey":{ },"bdText":"","bdMini":"2","bdMiniList":false,"bdPic":"","bdStyle":" 0","bdSize":"16"},"share":{ }};with(document)0[(getElementsByTagName('head')[0]||body).appendChild(createElement('script')) .src='http://bdimg.share.baidu.com/static/api/js/share.js?v=89860593.js?cdnversion='+~(-new Date()/36e5)];With the 2015 calendar opening a new page, the biotechnology industry has entered a new year. The GEN website recently looked forward to the technology and market that is expected to grow rapidly in 2015, summarizing the top ten trends in the bio-industry. They believe that these technologies will be an important driver of life sciences research and development, and help promote biotechnology into new areas. At the same time, M&A activity will continue to constitute a trend in the distribution of finance and resources, which is crucial to the development of the bio-industry.
Big data
Today, everyone is talking about the challenges of big data. Biostatisticians and bioinformatics experts are solving problems and developing complex solutions to handle massive amounts of information. We can be sure that big data will grow even bigger in 2015.
2. Biosimilars
Frost & Sullivan expects the market for biosimilars to grow from $1.2 billion in 2013 to $23 billion in 2019. As of mid-November, the European Medicines Agency (EMA) has approved more than 20 biosimilars. In July, the US FDA also accepted an application from Sandoz, a Novartis generics division. It is expected that there will be more applications in the US and Europe next year, and approval may be the case.
3. Clinical group science
Genomics technology, next-generation sequencing technology and biomarker research are gradually emerging from research-based laboratory work and entering the stage of clinical application. This stage has been set up as a genomics-based medical practice.
4. Ebola and other emerging viruses
The Ebola virus has caused a devastating blow to West Africa and has sporadically appeared in the West. Ebola may never disappear, and the MERS, H7N9 and H5N1 viruses may also be potential killers. With the rapid development of Ebola drugs, diagnostic and therapeutic companies have had a huge opportunity to deal with these emerging viruses.
5. Epigenetics
For young scientists who are looking for a promising career, they should consider epigenetic research. Closely linked to our genome, epigenetics is expected to exceed $783 million in market value over the next five years. They are expected to answer genetic questions that many genes cannot answer.
6. Immuno Oncology
Pfizer spent nearly $3 billion to reach an agreement with Merck in Germany to jointly develop PD-L1 antibodies to treat a variety of cancers. This is the latest in a series of deals aimed at developing drugs that help the body's immune system fight cancer.
7. M&A activities
Burrill's report pointed out that in the first nine months of 2014, the transaction volume of life sciences M&A activity reached $231.5 billion, compared to $131.8 billion last year. According to Biopharm Insight, many entities use M&A as a means to enhance their resources as healthcare companies and institutions consider the impact of the Affordable Care Act, economic recovery, and the need for capital and IT improvements.
8. Nanomedicine
Nanomedication allows a small amount of drug to target a specific part of the body. The dosage of nanomedicine is small, and its goal is to reduce costs, reduce side effects, and rapidly treat diseases.
9. Personalized medicine
Personalized medicine is rapidly evolving and is characterized by the use of regenerative medicine, tissue engineering, stem cells, genomic medicine, and pharmacogenomics. Many experts believe that the diagnosis and treatment tailored to each patient will be part of everyday medical practice over the next 10 years.
10. Synthetic biology
Craig Venter and colleagues are remodeling pigs by changing their genetic code to allow animals to grow out of the human lung for transplantation. Synthetic biologists also apply this technology to the development of biofuels, vaccines and antibodies, plants, industrial enzymes, and biobased chemicals.
Zhejiang Haisheng Medical Device Co., Ltd , https://www.hisernmedical.com